- Michael N. Dudley, Qpex Biopharma (USA)
- Glenn Dale, Bioversys (Switzerland)
- Carole A. Sable, CA Sable consulting (USA)
In this webinar, the speakers discussed the challenges and options of the clinical development of new fixed antibiotic combinations to restore or potentiate the activity of old antibiotics.
The speakers gave the following presentations:
- Beta-lactamase inhibitor combinations: It takes two to tango (Michael N. Dudley)
- An example of a potentiator combination (Glenn Dale)
Audience questions were answered at the end of the webinar.
This live webinar including an interactive Q&A session was broadcast on 23 August 2022, 17:00-18:30 CEST.
If you have questions or comments, please let us know: firstname.lastname@example.org.